Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JTECTSE:3446 -2.37%56 Current Ratio is 3.20 as of Mar. 2026, which is 14% below its 10-year median of 3.72. GuruFocus rates TSE:3446 with a GF Score™ of 56/100 and a GF Value™ of 円2,140.06 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 852 Medical Devices & Instruments companies, JTEC ranks better than 60.92% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. JTEC's current ratio for the quarter that ended in Mar. 2026 was 3.20.
JTEC has a current ratio of 3.20. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for JTEC's Current Ratio or its related term are showing as below:
TSE:3446'
s Current Ratio Range Over the Past 10 Years
Min: 1.69 Med: 3.72 Max: 8.99
Current: 3.2
During the past 9 years, JTEC's highest Current Ratio was 8.99. The lowest was 1.69. And the median was 3.72.
TSE:3446's Current Ratio is ranked better than 60.92% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 2.49
vs TSE:3446: 3.20
JTEC (TSE:3446) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
JTEC Current Ratio Related Terms
JTEC Current Ratio Historical Data
* Premium members only.
The historical data trend for JTEC's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:3446 vs ISRG, BDX, MDLN: Current Ratio Comparison
For the Medical Instruments & Supplies subindustry, JTEC's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JTEC Current Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JTEC's Current Ratio distribution charts can be found below:
* The bar in red indicates where JTEC's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JTEC (TSE:3446) has a Current Ratio of 3.20 as of Mar. 2026. This is 14% below median its historical median of 3.72. Over the past decade, JTEC's Current Ratio has ranged from 1.69 to 8.99. According to the industry distribution chart, JTEC ranks #333 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 39.1%.
Is JTEC's Current Ratio too high?
JTEC's current Current Ratio of 3.20 is 14% below median its 10-year median of 3.72. Over the past 10 years, this metric has ranged from a low of 1.69 to a high of 8.99. The Medical Devices & Instruments industry median Current Ratio is 2.49. JTEC's value of 3.20 is 28.5% above this industry median. Based on the distribution chart, JTEC ranks #333 out of 852 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, JTEC has a GF Score™ of 56/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JTEC's Current Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, JTEC ranks #333 out of 852 companies for Current Ratio. This puts JTEC in the upper half of its industry. The industry median Current Ratio is 2.49. JTEC's value of 3.20 is 28.5% above this benchmark. Historically, JTEC's own Current Ratio has ranged from 1.69 to 8.99 over the past decade. While the company's 10-year median is 3.72 vs. the industry median of 2.49, JTEC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.49, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JTEC's current Current Ratio of 3.20 is 28.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JTEC's current Current Ratio is 3.20, which is 14% below median its own 10-year median of 3.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JTEC stock overvalued right now?
Based on GuruFocus' analysis, JTEC (TSE:3446) is currently considered Significantly Undervalued. The stock's GF Value™ is 円2,140.06, compared to a current price of 円1,443.00 — trading 32.6% below its estimated fair value. The current Current Ratio is 3.20, which is 14% below median its 10-year median of 3.72 and 28.5% above the Medical Devices & Instruments industry median of 2.49. JTEC's overall GF Score™ is 56/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For JTEC (TSE:3446), the current Current Ratio is 3.20 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JTEC (TSE:3446) Overvalued in 2026?
Based on GuruFocus' analysis, JTEC stock appears to be undervalued.
The current stock price of 円1,443.00 is trading 32.6% below its estimated GF Value™ of 円2,140.06.
GuruFocus considers JTEC to be Significantly Undervalued.
Key valuation signals for TSE:3446:
Current Ratio: 3.20 (14% below median its 10-year median of 3.72)
GF Value™: 円2,140.06 vs. price of 円1,443.00 (32.6% below fair value)
Industry Position: 28.5% above the Medical Devices & Instruments median (#333 of 852)
No single metric tells the full story. See the TSE:3446 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JTEC Corp is engaged in developing, designing, manufacturing and sales of Automated Cell Culture System; X-ray Mirrors for Synchrotron Facilities; and Automated System in various fields. Its products in optical business include Kirkpatrick-Baez (KB) mirror, Advanced KB mirror (1D Wolter mirror), Montel mirror, Ellipsoidal mirror, 2D Walter mirror, Deformable mirror, Multi-channel mirror, X-ray focusing alignment system (JM1000 / 2000 series), Additional mirror shaping improvement, and Mirror coating. Its products in life science include CELLFLOAT products and Automated Cell Culture Systems.
56GF Score
Get the complete analysis for TSE:3446
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3446 has been successfully added to your 
